O

Orion Oyj
OMXH:ORNBV

Watchlist Manager
Orion Oyj
OMXH:ORNBV
Watchlist
Price: 45.23 EUR 1.89% Market Closed
Market Cap: 6.3B EUR
Have any thoughts about
Orion Oyj?
Write Note

Orion Oyj
PP&E Net

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Orion Oyj
PP&E Net Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company PP&E Net CAGR 3Y CAGR 5Y CAGR 10Y
O
Orion Oyj
OMXH:ORNBV
PP&E Net
€405.1m
CAGR 3-Years
8%
CAGR 5-Years
5%
CAGR 10-Years
5%
H
Herantis Pharma Oyj
OMXH:HRTIS
PP&E Net
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Orion Oyj
Glance View

Market Cap
6.4B EUR
Industry
Pharmaceuticals

Orion Oyj, a Finnish pharmaceutical and diagnostics company, has a storied history that dates back to 1917, when it was formed to meet the healthcare needs of the Finnish population. Over the decades, Orion has evolved into a key player in the European healthcare landscape, driven by its commitment to innovation and high-quality products. The company operates in two main segments: Prescription Pharmaceuticals, which includes medication for various therapeutic areas such as pain management, oncology, and neurology; and Animal Health, offering veterinary medicines and healthcare solutions. With a robust pipeline of new drugs and a focus on research and development, Orion is well-positioned to address the growing global demand for effective healthcare solutions. For investors, Orion presents a compelling narrative of stability and growth. The company has achieved consistent revenue growth and profitability, bolstered by strategic partnerships and an expansive international market presence. Orion maintains a strong balance sheet, allowing it to invest in future innovation while returning value to shareholders through dividends. The demand for its products is supported by an aging population and increasing health challenges, creating a favorable environment for sustained demand. In a rapidly changing world, Orion Oyj stands out as a resilient and adaptive company, embodying the prudent investment strategy espoused by legends like Warren Buffett and Charlie Munger.

ORNBV Intrinsic Value
60.97 EUR
Undervaluation 26%
Intrinsic Value
Price
O

See Also

What is Orion Oyj's PP&E Net?
PP&E Net
405.1m EUR

Based on the financial report for Jun 30, 2024, Orion Oyj's PP&E Net amounts to 405.1m EUR.

What is Orion Oyj's PP&E Net growth rate?
PP&E Net CAGR 10Y
5%

Over the last year, the PP&E Net growth was 6%. The average annual PP&E Net growth rates for Orion Oyj have been 8% over the past three years , 5% over the past five years , and 5% over the past ten years .

Back to Top